RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
企業コードRXST
会社名Rxsight Inc
上場日Jul 30, 2021
最高経営責任者「CEO」Kurtz (Ron M)
従業員数498
証券種類Ordinary Share
決算期末Jul 30
本社所在地100 Columbia Street
都市ALISO VIEJO
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号92656
電話番号19495217822
ウェブサイトhttps://www.rxsight.com/
企業コードRXST
上場日Jul 30, 2021
最高経営責任者「CEO」Kurtz (Ron M)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし